Skip to content

Construction of a predictive model for mortality risk after ICIs treatment in non-small cell lung cancer based on prospective longitudinal cohort

Construction of a predictive model for mortality risk after ICIs treatment in non-small cell lung cancer based on prospective longitudinal cohort

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080826
Enrollment
Unknown
Registered
2024-02-08
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Divided into survival group and death group according to prognostic outcomes:None

Sponsors

Nanchong Psychosomatic Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Pathologically or cytologically diagnosed as non-small cell lung cancer, with TNM staging of IIIB-IV, non-resectable, and receiving ICIs treatment according to the standard; (2) age over 18 years old, gender is not limited; (3) KPS score > 30 points, expected survival > 6 months; (4) no infection, hematology or immune deficiency disease, no use of immunosuppressants; (5) within 1 week before treatment, blood routine and biochemical test results, liver and kidney function are normal; (6) informed consent for this study.

Exclusion criteria

Exclusion criteria: (1) Those with mental disorders who cannot complete follow-ups; (2) Those with severe cardiovascular and cerebrovascular diseases and severe liver and kidney dysfunction; (3) Pregnant and lactating women; (4) Those participating in other drug clinical trials; (5) Other people who are not considered to meet the research requirements.

Design outcomes

Primary

MeasureTime frame
Survival rate;

Secondary

MeasureTime frame
Clinical features;

Countries

China

Contacts

Public ContactYongchuan Tan

Nanchong Psychosomatic Hospital

841582278@qq.com+86 137 7819 0245

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026